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Tbjective: Atrial fibrillation is one of the most common complications after cardiac
urgery. This study evaluates the risk factors of paroxysmal atrial fibrillation in
atients who underwent aortic valve replacement.
ethods: The study comprised 300 patients with aortic valve defects of either aortic
tenosis (n  150) or regurgitation (n  150) who underwent aortic valve replace-
ent. For each patient, 2-mode and Doppler echocardiographic examinations were
erformed in the preoperative period, early postoperative period, and long-term
bservation, and selected hemodynamic parameters were analyzed.
esults: Factors significantly associated with atrial fibrillation in patients with aortic
tenosis were heart failure (odds ratio  5.5), age 70 years or more (4.5), low (3.9)
nd high body mass index (1.7), maximal transvalvular gradient (3.7), low left
entricular ejection fraction (5.1), end-systolic (2.9) and end-diastolic intraventric-
lar septum thickness (1.5), and insignificant mitral regurgitation (1.9) in the
reoperative period; and left ventricular ejection fraction (4.4) and end-systolic
ntraventricular septum thickness (1.8) in the early postoperative period. In the
ortic regurgitation group, factors significantly associated with atrial fibrillation
ere age (1.8), left ventricular ejection fraction (3.7), left ventricular end-systolic
iameter (1.7), end-diastolic intraventricular septum thickness (1.7), left atrium
imension (4.1) and insignificant mitral regurgitation (2.5) in the postoperative
eriod; essential arterial hypertension (3.3), diabetes mellitus (2.6), and heart failure
n the history (4.5) in the preoperative period; and left ventricular ejection fraction
1.9) and left atrium dimension (2.9) in the early postoperative period.
onclusion: On the basis of the separated risk factors, all patients should be
reoperatively classified to applicable groups of risk of postoperative atrial fibril-
ation appearance, and the prophylactic treatment should be administered in the
roup of patients with the highest risk. It may essentially decrease the rate of
omplications and deaths, and, consequently, the costs of postoperative medical care.
trial fibrillation (AF), especially paroxysmal AF, is one of the most com-
mon complications after cardiac surgery. According to various authors, it
occurs with a frequency of 10% to 50%, depending on the definition and
iagnostic method.1 AF usually occurs 2 to 4 days after surgery and often r
uring the first 30 days of the postoperative period.2,3 Recently, AF has been not
ore often, probably because more patients undergo surgery in worse conditions,
ften associated with essential organic changes of heart. More postoperative ar-
hythmias are also connected with the broadening group of patients undergoing open
rocedures and thereby are the result of a reduction in contraindications. Suitable
reatment and prevention of postoperative AF are important for patients’ improved
ealth and faster rehabilitation, and for reduced hospitalization costs resulting from
horter lengths of stay in the hospital.4,5 Despite the existence of unique guidelines
he Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 6 1569
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A
CDrom the American Heart Association, European Society of
ardiology, and American College of Cardiology, there are
till doubts related to the selection of the best antiarrhythmic
rugs, timing of therapy, duration of treatment, and preven-
ion of renewed occurrences.6,7
Many authors have tried to evaluate the predictors of post-
perative AF. On the basis of available studies, they singled
ut inter alia the following postoperative risk factors: left
entricle failure in the preoperative period, age more than
5 years, reoperation, intraoperative and postoperative cat-
cholamines application, and respiratory failure.2,7-10
The aim of the study was to evaluate the risks factors of
aroxysmal AF in patients who underwent aortic valve
eplacement (AVR).
aterials and Methods
atient Population
he study comprised 300 patients with significant isolated aortic
alve defect caused by aortic stenosis (n 150) or regurgitation (n
150) who underwent AVR between 1999 and 2004 in the
epartment of Cardiac Surgery in Lodz, Poland. All study subjects
igned the informed consent form before inclusion in the study.
he study was approved by the local ethics committee.
The mean age of the patients was 61.5  5.4 years; there were
43 men (47.67%) and 157 women (52.33%). The mean body
urface area was 1.87  0.21, body mass index (BMI) was 26.75
3.42, and mean preoperative ejection fraction was 49.13% 
.8%. The following concomitant diseases were observed in this
roup of patients: arterial hypertension (n 195; 64.7%), diabetes
ellitus (n  60; 20%), renal failure (n  11; 3.67%), and severe
eart failure with a left ventricular ejection fraction (LVEF) of
5% or less (n  51; 17%).
All patients with the following conditions were excluded from
he study: aortic valve defect in the course of infective valve
efect, aortic valve defect as a result of myocardial infarction
omplication, history of myocardial infarction or cerebrovascular
vent, history of cardiac surgery, 1-step surgery of other valve
eplacement/plastics and/or surgical revascularization, surgery in
mergency/urgent mode, history of preoperative arrhythmias (eg,
F/flutter, ventricular arrhythmias, receiving antiarrhythmic
rugs, including beta-blockers), or other significant coexistent
Abbreviations and Acronyms
AF  atrial fibrillation
AVR  aortic valve replacement
BMI  body mass index
EDIVST end-diastolic intraventricular septum
thickness
ESIVST  end-systolic intraventricular septum
thickness
ICU  intensive care unit
LAd  left atrium dimension
LVEF  left ventricular ejection fractiononditions (eg, severe renal, pulmonary diseases, and neoplasms). p
570 The Journal of Thoracic and Cardiovascular Surgery ● DecEach patient who qualified for the AVR underwent coronary
ngiography (on average 33  7.7 hours before the surgery, range
9–63 hours), and no significant changes in coronary arteries were
ound. For each patient included in the study, 2-mode and Doppler
chocardiographic examinations were performed in the preopera-
ive period (up to 48 hours before the operation), in the early
ostoperative period (4–21 days after surgery; on average after 9
ays), and in long-term observation as a follow-up examination
18–24 months after the surgery; on average after 21 months). The
ollowing echocardiographic parameters were evaluated: LVEF,
eft ventricular end-systolic and end-diastolic diameters, end-
ystolic intraventricular septum thickness (ESIVST), end-diastolic
ntraventricular septum thickness (EDIVST), left atrium dimension
LAd), and mean and maximal transvalvular gradients for patients
ith aortic stenosis. All investigations were performed on Philips
ewlett Packard Sonos 2000AQ (Philips/Hewlett Packard, An-
over, Mass) and ACUSON Sequoia Echo C256 (Siemens, New
ork, NY) ultrasound systems. The detailed characteristics of the
atients are shown in Table 1.
Other heart valves were also evaluated during the echocardio-
raphic examinations. We did not observe any indications for the
eplacement/plastics of the mitral and/or tricuspid valves in the
xaminations. The frequencies of coexistence of other heart valve
efects are presented in Table 1.
urgical Intervention
ach patient included in the study underwent AVR with extracor-
oreal circulation. After removal of the native valve, all patients
ere implanted with mechanical valves from St Jude Medical (St
aul, Minn). Valve sizes ranged from 19 to 31 mm. All patients
nderwent AVR at normothermia with the use of antegrade cold
rystalloid St Thomas’ Hospital cardioplegic solution No. 2
4°C-6°C).
trial Fibrillation Evaluation
ostoperative paroxysmal AF was diagnosed on the basis of mul-
iple electrocardiographic examinations and confirmed in the 24-
our Holter monitoring. We considered paroxysmal AF when the
rrhythmia reverted spontaneously or after treatment to sinus
hythm within 1 week.
tatistical Analysis
tatistical analyses were performed with STATISTICA PL 7.0
StatSoft, Cracow, Poland) and SPSS 12.0 Software (SPSS Inc,
hicago, Ill). Normality was tested using the Shapiro–Wilk test.
he association between the potential risk factors and the
ortality rate was first evaluated by univariate analysis. For
ategoric variables, the chi-square test was used. The diagnostic
tility of continuous risk factors was estimated through the use
f receiver operating characteristic curves. The results were
xpressed in terms of the area under the curve with a 95%
onfidence interval for this area. Factors significant to at least a
value less than .10 were then analyzed using multivariate
ogistic regression (odds ratio, 95% confidence interval, P
alue), which was used to identify the independent clinical
redictors of postoperative AF.
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A
CDesults
ostoperative AF developed in 131 patients (43.7%), in-
luding 62 patients with aortic stenosis (41.3%) and 69
atients with aortic regurgitation (46.0%). The characteris-
ics of patients with aortic stenosis or regurgitation and AF
re presented and compared with those of patients without
F in Tables 2 and 3.
atients With Aortic Stenosis
ccording to statistical analysis, factors significantly asso-
iated with AF in patients who underwent AVR for aortic
tenosis were as follows: heart failure in the medical history
P  .001), age  70 years (P  .001), BMI both  30
g/m2 and  21 kg/m2 (P  .05 and P  .001, respec-
ABLE 1. Detailed characteristics of the 300 patients inclu
AS
n 150
Sex (M/F) n (%) 73 (48.7%)/77 (51.3%
Age (y) 63.33  9.85
Weight (kg) 74.17  13.98
BMI (kg/m2) 27.35 4.35
BSA 1.89 0.19
Mean gradient 50.88 23.7
Maximum gradient 86.54 20.6
LVEF (cm) 49.42  10.47
LVESd (cm) 3.48 0.73
LVEDd (cm) 5.12 0.77
ESIVST (cm) 1.8 0.2
EDIVST (cm) 1.43 0.16
LAd (cm) 4.2 0.58
MR n (%)
0 degree 58 (38.67%)
I degree 58 (38.67%)
I/II degree 21 (14.0%)
II degree 7 (4.67%)
II/III degree 6 (4.0%)
TR n (%)
0 degree 28 (18.7%)
I degree 38 (25.33%)
I/II degree 57 (38.0%)
II degree 21 (14.0%)
II/III degree 6 (4.0%)
AH n (%) 94 (62.67%)
DM n (%) 29 (19.33%)
HF n (%)
LVEF  50% 77
LVEF  35-50% 45
LVEF  35% 28
RF n (%) 5 (3.33%)
S, Aortic stenosis; AR, aortic regurgitation; BSA, body surface area; BM
nd-systolic diameter; LVEDd, left ventricular end-diastolic diameter; E
ntraventricular septum thickness; LAd, left atrium dimension; MR, mitral re
ellitus; HF, heart failure; RF, renal failure; NS, not significant.ively), maximal transvalvular gradient  85 mm Hg (P  [
The Journal of Thoracic001), LVEF  50% (P  .001), ESIVST  1.8 cm (P 
005) and EDIVST  1.4 cm (P  .05), insignificant mitral
egurgitation (P  .02) in the preoperative period, and
VEF  50% (P  .001) and ESIVST  1.8 cm (P  .02)
n the early postoperative period. Postoperative AF, in com-
arison with the conditions of the remaining 88 patients
ithout postoperative AF, was associated with the follow-
ng: increase in the length of intensive care unit (ICU) and
ospital stay (3.26  1.54 days vs 2.96  1.17 days,
espectively, P  .01, and 13.79  6.27 vs 11.92  5.64
ays, respectively, P  .001); greater incidence of stroke (5
8.1%] and 4 [4.5%] events in AF () and AF (), respec-
ively, P  .01); low output syndrome (17 [27.4%] and 22
in the study
AR P value
150 -
70 (46.7%)/80 (53.3%) -
59.61 10.37 .05
72.42 11.81 NS
26.57 3.81 .02
1.86 0.11 .05
- -
- -
48.99 9.47 NS
4.27 0.85 .001
5.97 0.94 .001
1.65 0.17 .005
1.31 0.15 .001
4.42 0.66 .05
49 (32.67%) NS
60 (40.0%) NS
13 (8.67) .02
26 (17.33) .001
2 (1.33) NS
22 (14.7%) NS
27 (18.0%) .01
54 (36.0%) NS
40 (26.7%) .01
7 (4.67%) NS
101 (67.33%) NS
31 (20.67%) NS
80
47
23 NS
6 (4.0%) NS
y mass index; LVEF, left ventricle ejection fraction; LVESd, left ventricular
, end-systolic intraventricular septum thickness; EDIVST, end-diastolic
tation; TR, tricuspid regurgitation; AH, arterial hypertension; DM, diabetesded
)
I, bod
SIVST
gurgi25%] events in AF () and AF (), respectively, P .05);
and Cardiovascular Surgery ● Volume 134, Number 6 1571
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1
A
CDnd early postoperative death (5 [8.1%] and 3 [3.4%] deaths
n AF () and AF (), respectively, P  .001) (Table 2)
ultivariate logistic regression analysis identified 7 inde-
endent predictors of postoperative paroxysmal AF in pa-
ients with aortic stenosis who underwent AVR: advanced
ge, history of heart failure, BMI  21 kg/m2, maximal
ABLE 2. Detailed characteristics of patients with aortic st
f patients without atrial fibrillation [AF()  88]: Univari
AF() n (%)
62 (41.3)
ex (M/F) n (%) 43 (69.4)/19 (30.
ge (y) 65.3 9.7
eight (kg) 72.5 11.8
reoperative risk factors
MI (kg/m2) 26.9 6.5
SA 1.88  0.21
ean gradient 51.3 20.3
aximum gradient 88.6 21.2
VEF (cm) 45.4 9.7
VESd (cm) 3.51 0.71
VEDd (cm) 5.13 0.87
SIVST (cm) 1.85 0.21
DIVST (cm) 1.44 0.17
Ad (cm) 4.24 0.61
R n (%) 43 (69.4)
R n (%) 51 (82.3)
A n (%) 39 (62.9)
M n (%) 12 (19.4)
F n (%) 39 (62.9)
F n (%) 2 (3.2)
arly postoperative risk factors
ean gradient 14.01 68
aximum gradient 28.1 8.8
VEF (cm) 49.4 3.9
VESd (cm) 3.27 0.98
VEDd (cm) 4.86 0.62
SIVST (cm) 1.79 0.17
DIVST (cm) 1.42 0.19
Ad (cm) 4.17 0.67
uration of ICU stay (d) 3.26 1.54
uration of hospital stay (d) 13.79 6.27
ajor complications
Stroke 5 (8.1)
Respiratory 4 (6.5)
LOS 17 (27.4)
ospital mortality 5 (8.1)
ong-term observations*
ortality 4 (7.0)
F, Atrial fibrillation; BSA, body surface area; BMI, body mass index; LVE
VEDd, left ventricular end-diastolic diameter; ESIVST, end-systolic intr
hickness; LAd, left atrium dimension; MR, mitral regurgitation; TR, tricuspid
F, renal failure; NS, not significant; ICU, intensive care unit; LOS, low outpu
omplications included pleural effusion, pneumonia, atelectasis, and othe
efined as the need for high dosages of inotropic medication and/or intraransvalvular gradient  85 mm Hg, LVEF  50% in the r
572 The Journal of Thoracic and Cardiovascular Surgery ● Decre- and early postoperative periods, and ESIVST  1.8 cm
efore the surgery (Table 3).
atients With Aortic Regurgitation
ccording to statistical analysis, factors significantly associ-
ted with AF in patients who underwent AVR for aortic
is and atrial fibrillation [AF() 62] compared with those
tatistical analysis
AF() n (%) P value
88 (58.7) -
34 (38.6)/54 (61.4) NS
58.6  8.4 .001
72.2  12.1 NS
26.3  3.8 .05
1.87  0.12 NS
49.8  24.2 NS
84.4  24.6 .001
48.9  11.4 .001
3.49  0.67 NS
5.09  0.99 NS
1.81  0.18 .005
1.41  0.27 .05
4.21  0.7 NS
49 (55.7) .02
71 (80.7) NS
55 (62.5) NS
17 (19.3) NS
34 (38.6) .001
3 (3.4) NS
13.79  6.4 NS
25.7  7.4 NS
52.1  8.1 .001
3.24  0.67 NS
4.84  0.97 NS
1.75  0.21 .02
1.41  0.22 NS
4.18  0.72 NS
2.96  1.17 .01
11.92  5.64 .001
4 (4.5) .01
4 (4.5) NS
22 (25.0) .05
3 (3.4) .001
5 (6.3) NS
ventricle ejection fraction; LVESd, left ventricular end-systolic diameter;
ricular septum thickness; EDIVST, end-diastolic intraventricular septum
gitation; AH, arterial hypertension; DM, diabetes mellitus; HF, heart failure;
drome. *All analyzed long-term parameters were insignificant. Respiratory
ditions requiring prolonged intubation (24 h) or reintubation. LOS was
c balloon pumping to sustain adequate hemodynamic status.enos
ate s
6)
F, left
avent
regur
t syn
r conegurgitation were as follows: age 70 years (P .05), LVEF
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A
CD50% (P  .005), left ventricular end-systolic diameter 
.15 cm (P  .02), EDIVST  1.35 cm (P  .05), LAd 
.25 cm (P .005), insignificant mitral regurgitation (P .01)
n the preoperative period, essential arterial hypertension 
60/100 mm Hg (second-degree hypertension according to the
uropean Society of Hypertension/European Society of Car-
iology 2007 guidelines) (P  .001), diabetes mellitus (P 
001), heart failure in the history (P .001), and LVEF 50%
P  .05) and LAd  4.15 cm (P  .005) in the early
ostoperative period. Postoperative AF, in comparison with the
onditions of the remaining 81 patients without postoperative
F, was associated with an increase in the length of ICU and
ospital stay (4.28  1.38 days vs 3.45  1.33 days, respec-
ively, P .001, and 15.14 2.21 days vs 12.93 3.36 days,
espectively, P .001); a greater incidence of stroke (5 [7.2%]
nd 3 [3.7%] events in AF () and AF (), respectively, P
001); low output syndrome (24 [34.8%] and 23 [28.4%]
vents in AF () and AF (), respectively, P .02); and early
ostoperative death (7 [10.1%] and 4 [4.9%] deaths in AF ()
nd AF (), respectively, P  .001). By comparing the long-
erm mortality, we observed a persistent significant difference
etween groups (6 [9.7%] and 3 [3.9%] deaths in AF () and
F (), respectively, P  .001) (Table 4). Multivariate log
ic regression analysis identified 7 independent predictors of
ostoperative paroxysmal AF in patients with aortic regurgi-
ation: history of heart failure, diabetes mellitus and essential
rterial hypertension, LVEF 50%, insignificant mitral regur-
itation in the preoperative period, and LAd 4.25 cm and
.15 cm in the pre- and early postoperative periods, respec-
ABLE 3. Preoperative and early postoperative significant
isk factors of atrial fibrillation after aortic valve replace-
ent for aortic stenosis
redictor P value Adjusted OR 95% CI
reoperative
Age  70 y* .001 4.5 1.7-5.2
BMI  30 kg/m2 .05 1.7 1.1-2.7
BMI  21 kg/m2* .001 3.9 2.1-4.6
Maximum gradient  85 mm .001 3.7 1.6-12.4
Hg* .001 5.1 1.7-9.6
LVEF  50%* .005 2.9 1.5-4.3
ESIVST  1.8 cm* .05 1.5 1.2-1.9
EDIVST  1.4 cm .02 1.9 1.1-4.7
MR .001 5.5 1.6-6.4
HF*
arly postoperative
LVEF  50%* .001 4.4 1.6-11.1
ESIVST  1.8 cm .02 1.8 1.2-2.4
R, Odds ratio; CI, confidence interval; BMI, body mass index; LVEF, left
entricle ejection fraction; ESIVST, end-systolic intraventricular septum
hickness; EDIVST, end-diastolic intraventricular septum thickness; MR,
itral regurgitation; HF, heart failure. *Independent risk factors.ively (Table 5). t
The Journal of Thoracicombined Group of Patients
ccording to statistical analysis, factors significantly asso-
iated with postoperative AF in patients who underwent
VR for aortic stenosis and regurgitation were as follows:
ge  70 years (P  .05), LVEF  50% (P  .001), left
entricular end-systolic diameter 3.85 cm (P .003) and
nd-diastolic diameter 5.5 cm (P .02), ESIVST 1.75
m (P .001) in the preoperative period; heart failure in the
edical history (P  .02), LVEF  50% (P  .001), left
entricular end-systolic diameter 3.75 cm (P .003), and
eft ventricular end-diastolic diameter  5.35 cm (P  .05)
n the early postoperative period; and LVEF  50% (P 
001) and left ventricular end-systolic and end-diastolic
iameters  3.6 cm (P  .003) and  5.1 cm (P  .04),
espectively, in the long-term observations. On the basis of
nivariate statistical analysis, we showed a significant cor-
elation between postoperative paroxysmal AF and the type
f aortic valve defect (P  .03 for aortic regurgitation),
ostoperative low cardiac output syndrome (P  .001), and
arly postoperative death (P  .002). Multivariate logistic
egression analysis showed that postoperative AF was an
ndependent risk factor of early postoperative death (odds
atio  3.9; 95% confidence interval 1.7–9.0; P  .002).
ostoperative AF was associated with an increase in the
ength of ICU and hospital stay (3.85  1.23 days vs 3.12
1.93 days, respectively, P .001, and 14.75 2.81 days
s 11.97  2.78 days, respectively, P  .001). Multivariate
ogistic regression analysis identified 6 independent predic-
ors of postoperative paroxysmal AF in patients who under-
ent AVR for an aortic valve defect: low BMI  21 kg/m2,
VEF  50%, left ventricular end-systolic diameter  3.85
m, ESIVST  1.75 cm in the preoperative period, and
VEF  50% in early postoperative period and the type of
ortic valve defect (aortic regurgitation) (Table 6).
iscussion
F is one of the most common complications after cardio-
urgical operations. It contributes to the worsening of the
ostoperative state and prognosis and increases the length of
CU stay, hospitalization, and hospital costs consider-
bly.11-13 For example, Kuduvalli and colleagues14 ana-
yzed predictors of in-hospital mortality in patients who
nderwent AVR. Among many risk factors, such as age
reater than 70 years, renal dysfunction, and heart failure,
hey observed that postoperative AF was a significant pre-
ictor of hospital mortality in patients after AVR. Similar
utcomes were also obtained in Kvidal and colleagues’
tudy,15 in which the authors showed that postoperative 
dvanced New York Heart Association functional class,
ure aortic regurgitation, and thromboembolism before sur-
ery decreased postoperative survival in patients who un-
erwent AVR. Postoperative AF may also cause other life-
hreatening complications, such as stroke, especially in
and Cardiovascular Surgery ● Volume 134, Number 6 1573
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1
A
CDatients with prosthetic valves. In Ruel and colleagues’
tudy,16 the authors evaluated the determinants of stroke
atients after AVR. They proved that postoperative AF, a
istory of coronary disease, and tilting-disc mechanical
rostheses were independent predictors of embolic stroke
fter AVR, which essentially worsened the prognosis and
rolonged the hospitalization. These results were confirmed
n our study. On the basis of univariate statistical analysis,
e showed that postoperative AF significantly increased the
ncidence of stroke and low output syndrome in patients
ith aortic stenosis and regurgitation. Furthermore, postop-
ABLE 4. Detailed characteristics of patients with aortic r
ith those of patients without atrial fibrillation [AF() 
AF() n (%)
69 (46.0)
ex (M/F) n (%) 36 (52.2)/33 (47.8
ge (y) 63.1 7.3
eight (kg) 72.4 12.5
reoperative risk factors
MI (kg/m2) 26.5 3.5
SA 1.86 0.27
VEF (cm) 43.3 7.5
VESd (cm) 4.33 0.51
VEDd (cm) 5.91 0.99
SIVST (cm) 1.64 0.15
DIVST (cm) 1.3 0.14
Ad (cm) 4.47 0.74
R n (%) 51 (73.9)
R n (%) 58 (84.1)
A n (%) 53 (76.8)
M n (%) 16 (23.2)
F n (%) 43 (62.3)
F n (%) 2 (3.0)
arly postoperative risk factors
VEF (cm) 44.7 6.9
VESd (cm) 4.09 0.49
VEDd (cm) 5.64 0.92
SIVST (cm) 1.62 0.15
DIVST (cm) 1.3 0.15
Ad (cm) 4.29 0.57
uration of ICU stay (d) 4.28 1.38
uration of hospital stay (d) 15.14 2.21
ajor complications
Stroke 5 (7.2)
Respiratory 3 (4.3)
LOS 24 (34.8)
ospital mortality 7 (10.1)
ong-term observations*
ortality 6 (9.7)
F, Atrial fibrillation; BSA, body surface area; BMI, body mass index; LVE
VEDd, left ventricular end-diastolic diameter; ESIVST, end-systolic intr
hickness; LAd, left atrium dimension; MR, mitral regurgitation; TR, tricuspid
F, renal failure; NS, not significant; ICU, intensive care unit; LOS, low ourative AF was essentially associated with the risk of post- s
574 The Journal of Thoracic and Cardiovascular Surgery ● Decperative mortality in both groups of patients. However, on
ultivariate statistical analysis in each of the investigated
roups of patients, for whom mortality was the end point
nd AF was one of the independent variables, we have not
bserved postoperative AF to be a significant predictor of
ostoperative mortality, probably because of the small num-
er of samples in each group. However, by analyzing a
ombined group of patients, we showed that postoperative
F was an independent risk factor of early postoperative
ortality (odds ratio  3.9, P  .002). In both analyzed
roups of patients, postoperative AF was connected with a
gitation and atrial fibrillation [AF()  69] in comparison
Univariate statistical analysis
AF() n (%) P value
81 (54.0) -
34 (42.0)/47 (58.0) NS
58.4  10.4 .05
71.7  11.7 NS
26.1  3.3 NS
1.88  0.22 NS
46.7  6.4 .005
4.05  0.95 .02
5.88  0.65 NS
1.65  0.22 NS
1.34 0.17 .05
4.25  0.65 .005
50 (61.7) .01
70 (86.4) NS
48 (59.3) .001
15 (18.5) .001
27 (33.3) .001
4 (4.9) NS
47.8  6.3 .05
3.97  0.82 NS
5.62  0.86 NS
1.63  0.13 NS
1.3  0.14 NS
4.15  0.61 .005
3.45  1.33 .001
12.93  3.36 .001
3 (3.7) .001
4 (4.9) NS
23 (28.4 ) .02
4 (4.9) .001
3 (3.9) .001
ventricle ejection fraction; LVESd, left ventricular end-systolic diameter;
ricular septum thickness; EDIVST, end-diastolic intraventricular septum
gitation; AH, arterial hypertension; DM, diabetes mellitus; HF, heart failure;
yndrome. *All analyzed long-term parameters were insignificant.egur
81]:
)
F, left
avent
regurignificant longer duration of ICU stay and hospitalization.
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A
CDFew studies present predictors of postoperative AF in
atients who underwent AVR. In Orlowska-Baranowska
nd colleagues’ study,17 the authors identified age, Ne
ork Heart Association functional class, history of preop-
rative paroxysmal AF, left ventricular mass index  300
upraventricular beats on 24-hour electrocardiography be-
ore surgery, presence of supraventricular tachycardia, su-
raventricular tachycardia of  5 beats, or a rate  120
eats/min as risk factors of postoperative paroxysmal AF.
y using multivariate analysis, they identified the following
variables as independent predictors: age, history of par-
xysmal AF, presence of  300 supraventricular beats/24
ours, and presence of supraventricular tachycardia. In Duc-
eschi and colleagues’ study,18 the authors included 30
atients and divided them into 2 groups according to the
bsence or evidence of post-AVR AF. Post-AVR paroxys-
al AF occurred in 19% of patients. They noticed that AF
ost-AVR was associated with advanced age, left atrial
nlargement, preoperative episodes of paroxysmal AF, use
f a warm blood cardioplegic solution and normothermia,
dministration of inotropic agents, prolonged assisted ven-
ilation, electrolyte imbalance, and atrioventricular and in-
raventricular conduction disorders. By using multivariate
ogistic regression analysis, the authors identified age, left
trial enlargement, a history of paroxysmal AF, and post-
perative electrolyte imbalance as independent correlates of
F, whereas the use of hypothermia seemed to be a protec-
ive factor. These results are partially consistent with the
utcomes obtained in our study. Both pre- and early post-
ABLE 5. Preoperative and early postoperative significant
isk factors of atrial fibrillation after aortic valve replace-
ent for aortic regurgitation
redictor P value Adjusted OR 95% CI
reoperative
Age  70 y .05 1.8 1.2–4.2
LVEF  50%* .005 3.7 1.6–6.7
LVESd  4.15 cm .02 1.7 1.1–3.6
EDIVST  1.35 cm .05 1.7 1.2–2.4
LAd*  4.25 cm .005 4.1 1.8–8.6
MR* .01 2.5 1.6–3.9
AH* .001 3.3 1.5–7.7
DM* .001 2.6 1.6–4.2
HF* .001 4.5 1.6–9.4
arly postoperative
LVEF  50% .05 1.9 1.3–4.7
LAd*  4.15 .005 2.9 1.7–4.5
R, Odds ratio; CI, confidence interval; LVEF, left ventricle ejection fraction;
VESd, left ventricular end-systolic diameter; LVEDd, left ventricular end-
iastolic diameter; EDIVST, end-diastolic intraventricular septum thick-
ess; LAd, left atrium dimension; MR, mitral regurgitation; AH, arterial
ypertension; DM, diabetes mellitus; HF, heart failure. *Independent risk
actors.perative LVEF  50% and history of heart failure were F
The Journal of Thoracicndependent predictors of postoperative AF. We also no-
iced that changes of some hemodynamic parameters, such
s ESIVST and EDIVST for patients with aortic stenosis
nd ESIVST, left ventricular end-systolic diameter, and
Ad for aortic regurgitation, significantly influenced the
ppearance of postoperative AF.
Despite the risk factors presented, we also found some
ther predictors that have not been mentioned in the avail-
ble studies, for example, low BMI and maximal transval-
ular gradient for patients with aortic stenosis, and a history
f insignificant mitral regurgitation, essential atrial hyper-
ension, and diabetes mellitus for patients with aortic regur-
itation. Low BMI as an independent predictor of postop-
rative AF in the patients with aortic stenosis and the
ombined group of patients who underwent AVR, irrespec-
ive of the type of valve defect, seems to be exceptionally
nteresting, because these results confirmed previous reports
uggesting that low BMI may worsen the prognosis and
ncrease the risk of cardiovascular events and mortality in
atients with heart diseases.19-22 Furthermore, in the othe
tudy we observed that low BMI and the previously stated
ssential arterial hypertension were also independent pre-
ictors of postoperative in-hospital death in patients who
nderwent AVR.23-25
In the present study, we also analyzed predictors of
ostoperative paroxysmal AF in the combined group of 300
atients who underwent AVR. We showed that in addition
o few other significant predictors, the type of aortic valve
efect, aortic regurgitation, was itself an independent risk
actor of postoperative AF. There are no available studies
ndicating that the type of valve defect, aortic regurgitation,
ight influence postoperative AF occurrence irrespective of
ther pre- and postoperative risk factors. It means that
atients with aortic regurgitation qualified for AVR should
e treated as patients with a higher risk of postoperative AF.
ABLE 6. Preoperative and early postoperative indepen-
ent risk factors of atrial fibrillation after aortic valve
eplacement
redictor P value Adjusted OR 95% CI
reoperative
Type of aortic defect, AR .03 1.7 1.1–2.6
BMI  21 kg/m2 .004 4.1 1.6–10.7
LVEF  50% .03 1.7 1.1–2.7
LVESd  3.85 cm .008 1.9 1.2–3.0
ESIVST  1.75 cm .02 1.7 1.1–2.7
arly postoperative
LVEF  50% .001 2.8 1.8–4.5
R, Odds ratio; CI, confidence interval; AR, aortic regurgitation; BMI, body
ass index; LVEF, left ventricular ejection fraction; LVESd, left ventricular
nd-systolic diameter; ESIVST, end-systolic intraventricular septum
hickness.urther studies are necessary to confirm these results.
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1
A
CDThe present study has some limitations, which are mainly
onnected with the number of patients included in the study
nd consequently the number of patients with postoperative
F. We also did not analyze many other potential AF
redictors, especially from the intraoperative period. How-
ver, we were aware that it would have been difficult to
xamine all possible risk factors, so we focused specifically
n the hemodynamic parameters and the impact of postop-
rative AF on them.
onclusions
e separated the following independent risk factors of
ostoperative AF occurrence: advanced age, history of heart
ailure, low BMI, maximal transvalvular gradient, low ejec-
ion fraction, and preoperative ESIVST for patients with
ortic stenosis; and history of heart failure, diabetes mellitus
nd essential arterial hypertension, low LVEF, insignificant
itral regurgitation in the preoperative period, and high
Ad for patients with aortic regurgitation. In the combined
roup of patients, the following predictors were significant
nd independent: type of valve defect (aortic regurgitation),
ow BMI, low LVEF, left ventricular end-systolic diameter,
nd ESIVST in the preoperative period, and low LVEF
arly after AVR. A large, multicenter study should be
erformed to confirm these results.
The study may have an important influence on the manage-
ent of patients who undergo AVR. On the basis of the
eparated risk factors, all patients should be preoperatively
lassified to applicable groups of risk of postoperative AF
ppearance, and the prophylactic treatment (pre- and postop-
rative) should be administered in the highest risk group of
atients. It may essentially decrease the rate of complications
nd deaths, and the costs of postoperative medical care.
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